Mosaic (MOS) Q2 2025: $100M+ Cost Cuts Drive Potash Output Guidance to 9.5M Tons
Mosaic’s Q2 2025 marks a decisive operational inflection as asset upgrades and cost reductions position the company to capitalize on tight global fertilizer markets. With maintenance disruptions now behind and cost initiatives exceeding $100 million, Mosaic is poised for volume, margin, and cash flow acceleration in the second half. Management signals further upside as Brazil and biosciences scale, while elevated phosphate and potash pricing underpin a constructive outlook into 2026.
Summary
- Asset Reliability Reset: Major U.S. phosphate upgrades are complete, setting up higher volumes and lower unit costs.
- Cost Structure Transformation: Over $100 million in realized cost reductions, with a new $250 million target by 2026.
- Volume Upside Leveraged: Raised potash production guidance and strong Brazil performance drive confidence in H2 earnings growth.
Performance Analysis
Mosaic’s Q2 2025 results reflect a business in transition, with near-term earnings noise masking underlying improvement. Net income swung to $411 million, aided by favorable FX and marketable securities gains, while adjusted EBITDA was $566 million, slightly down year-over-year due to one-off provisions and elevated maintenance costs. The core story is not in the reported numbers, but in the operational reset now complete across key assets.
Phosphate production was hampered by extended maintenance, pushing unit costs to $126 per ton—well above target—but management expects a return to normalized run rates and cost structure in Q3 as all major reliability projects are now finished. Potash saw higher cash costs from timing of turnarounds, but Esterhazy is back online and Calance will run through year-end to meet robust demand. Brazil’s Fertilizantes segment delivered $150 million EBITDA despite credit headwinds, and is on track for even stronger Q3 results as cost reductions and higher distribution margins take hold.
- Maintenance Drag Peaks: Over $50 million in non-recurring phosphate turnaround costs in Q2, now largely behind.
- Fixed Cost Leverage: 85% of phosphate conversion costs are fixed, so higher volumes will rapidly improve per-ton economics.
- Brazil Surges: Fertilizantes cost actions and market access drive segment EBITDA, with biosciences to become EBITDA positive in Q4.
With asset health restored and market conditions tight, Mosaic is set for a significant sequential earnings step-up in Q3 and beyond.
Executive Commentary
"Our hard work to improve operating performance is paying off. It's apparent in our Brazil results, and we expect to see improvements in our U.S. phosphate production business now that the vast majority of our work to enhance reliability is complete."
Bruce Bodine, President and Chief Executive Officer
"We have achieved $150 million cost reduction targets established last year... we're now extending our goal from $150 to $250 million. Going forward, this additional $100 million in value capture is expected to be achieved by the end of 2026."
Luciano Ciani-Perez, Executive Vice President and Chief Financial Officer
Strategic Positioning
1. Asset Health and Production Upside
Mosaic’s U.S. phosphate assets have undergone an extraordinary reliability overhaul, with all major maintenance complete and no further planned disruptions. The New Wales, Bartow, Riverview, and Louisiana plants are now running at or near target rates, positioning the company to achieve its 8 million ton annualized run rate and analyst day cost targets by year-end. This reset unlocks fixed cost absorption and reduces the risk of unplanned outages.
2. Market Access and Geographic Agility
Mosaic’s global distribution network is a core competitive advantage, allowing the company to redirect volumes to regions with the strongest demand. The new Pomerantse facility in Brazil adds 1 million tons of capacity in a high-growth region, while the company’s ability to flex tons globally is critical given uneven demand in the Americas and tight supply elsewhere.
3. Cost Structure Transformation
Cost reduction is now a structural lever, not a one-off. Mosaic surpassed its initial $150 million cost savings target, largely through Fertilizantes and SG&A initiatives, and has set a new $250 million goal by 2026. This will be achieved through further automation, supply chain optimization, and fixed cost leverage as volumes ramp. Brazil’s cost transformation is already visible in segment margins, and further upside is expected as distribution margins expand and biosciences scale.
4. Product and Segment Diversification
Mosaic Biosciences, the company’s crop input innovation platform, more than doubled revenue in H1 and is set to turn EBITDA positive in Q4. Management sees a path to $250 million EBITDA from biosciences over time, driven by new product launches and regulatory approvals. China is also emerging as a material contributor, with potential to double or triple its $30 million H1 run-rate.
5. Capital Allocation and Balance Sheet Flexibility
Stronger free cash flow in H2 will enable debt reduction and capital returns, with additional asset sales (Carlsbad, Tokori) and completed projects (Hydroflow, Pomerantse) freeing up capital for higher-return uses. Management is focused on reclaiming and redeploying capital to maximize shareholder value.
Key Considerations
Mosaic’s Q2 marks a pivotal transition from operational catch-up to proactive market capture, with the company leveraging improved asset health, cost structure, and global reach to capitalize on supportive industry dynamics.
Key Considerations:
- Phosphate Volume Recovery: Asset upgrades are done, so the pace and consistency of volume ramp in H2 will be a key margin driver.
- Potash Market Tightness: Maintenance at competitors and robust global demand support elevated prices and justify running Calance through year-end.
- Brazil Credit Environment: Fertilizantes growth is robust, but credit risk could limit customer base expansion; management is prioritizing risk-adjusted returns.
- Biosciences Scaling: New products and regulatory approvals will determine the speed of EBITDA contribution from this high-potential segment.
- Cost Savings Execution: Delivery of the incremental $100 million in targeted cost reductions will be critical for margin expansion and valuation re-rating.
Risks
Execution risk remains around the ramp of phosphate production and the sustainability of cost reductions, especially if unplanned outages or weather events occur in Florida. Brazil’s macro and credit environment could constrain Fertilizantes growth, while global fertilizer demand is sensitive to crop prices and government policy. Tariff and trade dynamics add further unpredictability, particularly for U.S. phosphate imports and raw material sourcing.
Forward Outlook
For Q3 2025, Mosaic guided to:
- Phosphate sales volumes of 1.8 to 2.0 million tons, reflecting confidence in asset reliability.
- Potash production guidance raised to 9.3 to 9.5 million tons for the full year.
For full-year 2025, management maintained:
- Phosphate production of 6.9 to 7.2 million tons, reflecting earlier downtime but full ramp in H2.
Management emphasized that Q3 EBITDA is expected to be “significantly higher” sequentially, with margin tailwinds from higher volumes, lower turnaround costs, and stable to rising realized prices in both potash and phosphate.
- Phosphate conversion costs per ton expected to decline as volumes normalize.
- Fertilizantes segment poised for record EBITDA, contingent on sales execution amid credit constraints.
Takeaways
Mosaic’s operational reset and cost actions set the stage for strong H2 earnings leverage, with upside from both volume recovery and margin expansion as global fertilizer markets remain tight.
- Cost and Reliability Inflection: With major maintenance behind, Mosaic is positioned for sustained volume and margin gains, especially in phosphate.
- Brazil and Biosciences as Growth Engines: Fertilizantes and biosciences are emerging as significant EBITDA contributors, offering diversification beyond core commodities.
- Watch Volume and Margin Execution: The pace of phosphate output recovery and realization of cost targets will be key to unlocking further upside through 2026.
Conclusion
Mosaic’s Q2 2025 was a reset quarter, with near-term earnings noise overshadowed by substantial progress on asset reliability and cost structure. With major operational bottlenecks cleared and cost savings ahead of plan, the company is strategically positioned to capitalize on tight global fertilizer markets and deliver accelerating earnings in the second half and beyond.
Industry Read-Through
Mosaic’s results reinforce the global fertilizer sector’s return to tight market conditions, with supply constraints and robust ag demand supporting elevated prices in both phosphate and potash. Competitors facing maintenance or supply disruptions will see similar fixed cost leverage as volumes recover, while those lacking Mosaic’s distribution reach may struggle to flex to the highest-value markets. Brazil’s credit-driven consolidation could favor scale players, and the rapid scaling of biosciences signals rising demand for crop input innovation. Tariff volatility and government policy remain key sector watchpoints.